Our mission

We aim to achieve long-term survival for cancer patients by bridging the medical physics of ablative interventions and immuntherapy to enable individualized cancer care.


Goals

See some of the most important goals for this research program.

read more

Goals

  • To gain a fundamental understanding of the mode-of-action of ablative technologies focusing on immunological and Tumor MicroEnvironment (TME) effects.  
  • To develop innovative immune modulatory therapies for in vivo programming of (innate) immune cells and fibroblasts for combination therapies. 
  • To develop (early) clinical feasibility and translational studies, guided by early health technology assessments to ensure responsible research and innovation.  
  • To train next generation professionals to bridge the medical physics of ablative interventions and immunotherapy. 


Research groups contributing to this research program

Spokesperson(s) for this research program


Spokesperson

prof. dr. Gosse Adema

contact form